ADORA2A, adenosine A2a receptor, 135

N. diseases: 213; N. variants: 10
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Attention deficit hyperactivity disorder
0.020 Biomarker disease BEFREE Altogether, the present findings suggested that the ADORA2A gene and the interaction of ADORA2A and DRD2 genes may play a role in anxiety disorders in children and adolescents with ADHD. 30946941 2019
CUI: C0000768
Disease: Congenital Abnormality
Congenital Abnormality
0.010 GeneticVariation group BEFREE In the current edition, Fujioka and colleagues report on four Japanese patients with Parkinson disease (PD) and severe postural abnormalities treated with istradefylline (adenosine A2A receptor antagonist); further, dopamine agonists were with- drawn. 31469906 2019
CUI: C0003864
Disease: Arthritis
Arthritis
0.010 Biomarker disease BEFREE Wild-type and Adora2a-deficient mouse KRN T cell receptor-transgenic CD4 T cells specific for glucose-6-phosphate isomerase (GPI)/I-A<sup>g7</sup> were transferred into immunodeficient Tcra<sup>-/-</sup> I-A<sup>g7</sup> -expressing mice to induce arthritis. 30516351 2019
CUI: C0021051
Disease: Immunologic Deficiency Syndromes
Immunologic Deficiency Syndromes
0.010 Biomarker group BEFREE Wild-type and Adora2a-deficient mouse KRN T cell receptor-transgenic CD4 T cells specific for glucose-6-phosphate isomerase (GPI)/I-A<sup>g7</sup> were transferred into immunodeficient Tcra<sup>-/-</sup> I-A<sup>g7</sup> -expressing mice to induce arthritis. 30516351 2019
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.010 Biomarker disease BEFREE Adenosine interaction with adenosine receptor A2a promotes gastric cancer metastasis by enhancing PI3K-AKT-mTOR signaling. 31339445 2019
CUI: C0028754
Disease: Obesity
Obesity
0.010 Biomarker disease BEFREE These findings indicate that Adora2a-mediated signaling in vascular endothelial cells disrupts the BBB in dietary obesity, and implicate cerebrovascular dysfunction as the underlying mechanism for deficits in synaptic plasticity and cognition with obesity and insulin resistance.<b>SIGNIFICANCE STATEMENT</b> The blood-brain barrier (BBB) restricts the entry of circulating factors into the brain, but obesity promotes BBB breakdown in humans and animal models. 30886019 2019
CUI: C0038454
Disease: Cerebrovascular accident
Cerebrovascular accident
0.010 Biomarker group BEFREE Mice specifically deficient in endothelial Adora2a (Adora2a<sup>ΔVEC</sup> ) showed reduced leukocyte infiltration, BBB leakage, and oedema after stroke, along with attenuated downstream proinflammatory markers, both in vivo and in vitro. 30931525 2019
CUI: C0039103
Disease: Synovitis
Synovitis
0.010 Biomarker disease BEFREE Adenosine A2A Receptor Mediates Inhibition of Synovitis and Osteoclastogenesis after Electroacupuncture in Rats with Collagen-Induced Arthritis. 30956681 2019
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.010 Biomarker disease BEFREE Endothelial Adora2a Activation Promotes Blood-Brain Barrier Breakdown and Cognitive Impairment in Mice with Diet-Induced Insulin Resistance. 30886019 2019
CUI: C0349217
Disease: Depressive episode, unspecified
Depressive episode, unspecified
0.010 GeneticVariation disease BEFREE Here, we examined an association between a single nucleotide polymorphism in A<sub>2A</sub> receptor gene (ADORA2A, rs2298383 SNP) with current depressive episode and symptom profile. 30511252 2019
Secondary malignant neoplasm of lymph node
0.010 Biomarker disease BEFREE Adenosine A2a receptor promotes lymphangiogenesis and lymph node metastasis. 31413909 2019
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.010 Biomarker disease BEFREE Adenosine interaction with adenosine receptor A2a promotes gastric cancer metastasis by enhancing PI3K-AKT-mTOR signaling. 31339445 2019
CUI: C1112433
Disease: Thromboembolic stroke
Thromboembolic stroke
0.010 AlteredExpression disease BEFREE Thromboembolic stroke induced Adora2a expression in the brain. 30931525 2019
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.390 Biomarker group BEFREE CYP1A2 is responsible for the majority of the metabolism of caffeine, and ADORA2A has been linked to caffeine-induced anxiety. 30248915 2018
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.330 Biomarker disease BEFREE Interestingly, paired-pulse depression was similarly sensitive to disruption by ATP P2Y and adenosine A2A receptor antagonists. 29277734 2018
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.330 Biomarker disease BEFREE Behavioral changes induced through adenosine A2A receptor ligands in a rat depression model induced by olfactory bulbectomy. 29761007 2018
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.100 Biomarker disease BEFREE Long-term Outcome of Adenosine A2A Receptor Antagonist on Lower Urinary Tract Symptoms in Male Parkinson Disease Patients. 29672326 2018
CUI: C0236734
Disease: Caffeine related disorders
Caffeine related disorders
0.100 Biomarker group BEFREE Using genetic and candidate gene approaches, we show that among a variety of protein, Wls interacts with the dopamine transporter (target of cocaine), cannabinoid receptors (target of THC), Adenosine A2A receptor (target of caffeine), and SGIP1 (endocytic regulator of cannabinoid receptors). 28734904 2018
CUI: C0236734
Disease: Caffeine related disorders
Caffeine related disorders
0.100 GeneticVariation group BEFREE Here, we briefly review the drivers of this inter-individual variation in caffeine response, focusing on the impact of common polymorphisms within two genes, CYP1A2 and ADORA2A. 28853006 2018
CUI: C0003467
Disease: Anxiety
Anxiety
0.070 Biomarker disease BEFREE CYP1A2 is responsible for the majority of the metabolism of caffeine, and ADORA2A has been linked to caffeine-induced anxiety. 30248915 2018
CUI: C0004352
Disease: Autistic Disorder
Autistic Disorder
0.040 AlteredExpression disease BEFREE This study investigated the influence of adenosine A2A receptor activity on C-C and C-X-C chemokine receptors involved in autism in the BTBR mouse model. 28421534 2018
CUI: C0011570
Disease: Mental Depression
Mental Depression
0.030 Biomarker disease BEFREE Behavioral changes induced through adenosine A2A receptor ligands in a rat depression model induced by olfactory bulbectomy. 29761007 2018
CUI: C0011570
Disease: Mental Depression
Mental Depression
0.030 Biomarker disease BEFREE Interestingly, paired-pulse depression was similarly sensitive to disruption by ATP P2Y and adenosine A2A receptor antagonists. 29277734 2018
CUI: C0344315
Disease: Depressed mood
Depressed mood
0.030 Biomarker phenotype BEFREE Interestingly, paired-pulse depression was similarly sensitive to disruption by ATP P2Y and adenosine A2A receptor antagonists. 29277734 2018
CUI: C0344315
Disease: Depressed mood
Depressed mood
0.030 Biomarker phenotype BEFREE Behavioral changes induced through adenosine A2A receptor ligands in a rat depression model induced by olfactory bulbectomy. 29761007 2018